THC blood level laws by state, driving coordination research, reaction time studies, breathalyzer technology, legal consequences, and how cannabis impairment compares to alcohol.
Safe driving requires the integration of multiple cognitive and motor functions simultaneously: attention to multiple visual fields, rapid processing of changing conditions, appropriate reaction time, lane tracking, speed management, and hazard anticipation. Cannabis affects several of these capacities through its action on the endocannabinoid system in the brain regions responsible for each function.
THC acts on CB1 receptors in the cerebellum (coordinating motor control and balance), the prefrontal cortex (executive function, decision-making, attention), the basal ganglia (procedural motor function), and the hippocampus (working memory). The aggregate effect at intoxicating doses includes: slowed reaction time, impaired divided attention, difficulty maintaining lane position (increased lateral deviation), and altered time and distance perception. At moderate to high doses, short-term memory deficits affect driving decision-making — drivers may forget a recently observed road condition or traffic rule.
Importantly, the driving impairment profile of cannabis differs from alcohol in several notable ways that make crash risk comparisons complex. While alcohol tends to increase risk-taking behavior, overconfidence, and speed, cannabis-impaired drivers typically attempt to compensate for their perceived impairment: they slow down, increase following distances, and take fewer risks. This compensation partially — but not fully — offsets the underlying impairment in lateral control and reaction time.
The most extensive body of cannabis driving impairment research comes from driving simulator studies, on-road studies with instrumented vehicles, and epidemiological crash data analysis.
Simulator studies consistently show that cannabis impairs lateral lane control — the ability to maintain a consistent lateral position within a lane — in a dose-dependent fashion. A foundational series of studies at the University of Maastricht using standardized road tracking tests showed that cannabis at THC doses corresponding to moderate recreational use (approximately 100-300 mcg/kg body weight) produced lateral position deviations of 3-5 cm, comparable in magnitude to approximately 0.08% BAC alcohol, while impairment at lower doses was substantially less. Reaction time to hazards is slowed by approximately 10-20% at moderate cannabis doses.
A critical difference from alcohol: driving simulator performance under cannabis tends to improve somewhat after the acute peak intoxication period — within 3-4 hours of smoking, many experienced users show near-baseline performance on standard driving tasks. By contrast, alcohol impairment is more consistent through its blood concentration curve. This suggests that the duration of meaningful driving impairment from smoked or vaped cannabis is shorter than its legal detection window (which can show THC for days to weeks in regular users).
| State | Law Type | THC Limit / Standard | Notes |
|---|---|---|---|
| Washington | Per se | 5 ng/mL D9-THC blood | First per se law in a recreational state |
| Montana | Per se | 5 ng/mL | |
| Nevada | Per se | 2 ng/mL | Also 5 ng/mL for THC metabolites |
| Pennsylvania | Per se (zero metabolite) | 1 ng/mL (any metabolite) | Extremely strict; catches past use |
| Ohio | Per se | 2 ng/mL D9-THC | Also 10 ng/mL for THC-COOH metabolite |
| Illinois | Per se | 5 ng/mL | |
| Arizona, Georgia, Indiana, Utah, Wisconsin | Zero tolerance | Any detectable THC or metabolite | Can capture past use with no current impairment |
| California, Colorado, Oregon (most states) | Behavioral impairment | Actual impairment must be proven | Based on driving behavior, field sobriety, officer observations |
The fundamental challenge in cannabis-impaired driving law is that blood THC concentration is a poor proxy for driving impairment — especially in frequent cannabis users. This contrasts sharply with alcohol, where blood alcohol concentration (BAC) has a well-established dose-response relationship with impairment across most individuals.
The reasons THC blood levels diverge from impairment levels are pharmacokinetic. After smoking or vaping cannabis, blood THC concentrations peak rapidly (within minutes) and then decline steeply — typically falling below 5 ng/mL within 3-4 hours in occasional users. Peak impairment roughly tracks this acute phase. However, in chronic heavy users, baseline blood THC can remain above 5 ng/mL for 24-48 hours or more due to redistribution of THC from fat stores back into blood, even without recent use and without meaningful impairment.
Several expert panels — including the National Academy of Sciences, Engineering and Medicine in its 2017 cannabis report — have explicitly stated that there is insufficient evidence to establish a reliable blood THC per se limit corresponding to impairment. The 5 ng/mL figure adopted by Washington and other states was a political decision made in the absence of a scientific consensus, as legislators needed a concrete number to enforce.
| Factor | Cannabis | Alcohol (0.08% BAC) |
|---|---|---|
| Crash odds increase | ~1.3-2x (meta-analyses vary) | ~5-7x |
| Risk-taking behavior | Typically decreases (compensation) | Significantly increases |
| Speed behavior | Tends to slow down | Tends to speed up |
| Reaction time | Slowed 10-20% at moderate doses | Slowed 15-25%+ at 0.08% |
| Lane tracking | Moderately impaired | Significantly impaired |
| Impairment duration | Acute effects 1-4 hours (smoked) | Correlates with BAC clearance (~1 hr/drink) |
| Detection window | Days to weeks (urine); hours (blood/saliva) | Hours only |
| Combined with other substance | Cannabis + alcohol = synergistic impairment increase | Cannabis + alcohol = synergistic impairment increase |
A cannabis DUI (Driving Under the Influence) or DUID (Driving Under the Influence of Drugs) conviction carries serious legal consequences in all US states and internationally. Consequences typically include: license suspension (90 days to 1+ year for a first offense), fines ($500-$5,000 depending on state and circumstances), mandatory drug/alcohol education programs, possible jail time (up to 1 year for misdemeanor first offense; felony charges if injury or death involved), and a permanent criminal record affecting employment, housing, and professional licensing.
For commercial driver’s license (CDL) holders, cannabis impairment charges typically result in CDL disqualification — ending a trucking, bus, or taxi career. For drivers under 21, zero-tolerance laws in most states mean any detectable cannabis can result in DUI charges even in behavioral impairment states. For medical cannabis patients, most states explicitly do not provide immunity from DUID charges — having a medical cannabis card does not protect you from impaired driving enforcement.
States with per se THC limits include Washington and Montana (5 ng/mL), Nevada (2 ng/mL), Pennsylvania (1 ng/mL), Ohio (2 ng/mL), and Illinois (5 ng/mL). Several states use zero tolerance (any detectable THC). The majority of states use behavioral impairment standards requiring proof of actual driving impairment rather than a blood concentration alone. No scientifically validated THC concentration equivalent to 0.08% BAC alcohol impairment exists — existing per se limits were set as policy decisions.
Cannabis approximately doubles crash odds; alcohol at 0.08% BAC increases them by 5-7 times. Cannabis-impaired drivers tend to slow down and compensate; alcohol-impaired drivers tend to speed up and take more risks. Both substances slow reaction time and impair lane tracking, but the magnitude differs. Combining cannabis and alcohol produces synergistic impairment substantially greater than either alone.
Standard field sobriety tests were validated for alcohol, not cannabis — particularly the HGN nystagmus test. Drug Recognition Expert (DRE) evaluations using a 12-step protocol are more accurate but take 45-60 minutes. Oral fluid (saliva) devices detect recent THC use within 4-8 hours but do not measure impairment. No roadside device currently provides a validated measure of cannabis impairment level comparable to a breath alcohol test.
Several companies are developing cannabis breath testing technology — Hound Labs, Cannabix Technologies, and SannTek among them — but none had received widespread law enforcement adoption. The technical challenge is that THC in breath is at picogram concentrations, and more fundamentally, breath THC does not reliably predict impairment level. The goal of a roadside impairment test (rather than a use detection test) remains scientifically unsolved for cannabis.